The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nurofen Express Maximum Strength 400 mg tablets



PCO Manufacturing Ltd.PPA0465/430/001

Main Information

Trade NameNurofen Express Maximum Strength 400 mg tablets
Active SubstancesIbuprofen
Dosage FormCoated tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/430/001

Group Information

ATC CodeM01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued04/08/2017
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licencemaximum strength 400 mg, maximum pack size 24, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications. For use in adults and children over 12 years.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back